Update definition of SubstanceDefinition.Representaiton.type

XMLWordPrintableJSON

    • Type: Change Request
    • Resolution: Persuasive
    • Priority: Medium
    • FHIR Core (FHIR)
    • R5
    • Biomedical Research & Regulation
    • SubstanceDefinition
    • Hide

      Agreed on call 28th July

      Show
      Agreed on call 28th July
    • Norman Gregory/Catherine Hosage Norman: 19-0-0
    • Clarification
    • Non-substantive
    • R5

      Request to change the definition of SubstanceDefinition.Representation.type to accommodate the FDA PQ/CMC requirement of supporting the methods used for substance characterization in eCTD M3.

      Change definition —

      FROM: The type of structure (e.g. Full, Partial, Representative).

      TO: The kind of representation (e.g. full, partial) or the technique used to derive the analytical characterization of the substance (e.g. x-ray, HPLC, NMR, peptide mapping, ligand binding assay, etc.).

       

            Assignee:
            Rik Smithies
            Reporter:
            Smita Hastak
            Catherine Hosage Norman, Rik Smithies, Smita Hastak, vdesai
            Watchers:
            1 Start watching this issue

              Created:
              Updated:
              Resolved: